RWA
MRNA icon

Ropes Wealth Advisors’s Moderna MRNA Stock Holding History

Ropes Wealth Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$368K Buy
3,566
+532
+18% +$59.3K 0.07% 191
2023
Q2 		$369K Sell
3,034
-47
-2% -$6.27K 0.06% 205
2023
Q1 		$473K Sell
3,081
-42
-1% -$6.93K 0.09% 180
2022
Q4 		$561K Sell
3,123
-145
-4% -$23.7K 0.1% 161
2022
Q3 		$386K Hold
3,268
– – 0.08% 172
2022
Q2 		$467K Buy
3,268
+300
+10% +$42.9K 0.1% 178
2022
Q1 		$511K Sell
2,968
-6
-0.2% -$1.01K 0.09% 194
2021
Q4 		$755K Sell
2,974
-171,808
-98% -$50.2M 0.13% 130
2021
Q3 		$67.3M Sell
174,782
-96,848
-36% -$35.7M 10.78% 1
2021
Q2 		$63.8M Hold
271,630
– – 10.1% 1
2021
Q1 		$43.2M Sell
271,630
-1,270,188
-82% -$184M 7.58% 1
2020
Q4 		$161M Sell
1,541,818
-19,232
-1% -$1.95M 24.99% 1
2020
Q3 		$110M Sell
1,561,050
-232,403
-13% -$16.2M 21.39% 1
2020
Q2 		$115M Sell
1,793,453
-961,365
-35% -$52.6M 23.5% 1
2020
Q1 		$82.5M Sell
2,754,818
-1,376,108
-33% -$31.7M 20.87% 1
2019
Q4 		$80.8M Sell
4,130,926
-857,823
-17% -$15.2M 17.41% 1
2019
Q3 		$79.4M Sell
4,988,749
-824,100
-14% -$12.2M 16.85% 1
2019
Q2 		$85.1M Buy
5,812,849
+5,812,244
+960,701% +$125M 17.96% 1
2019
Q1 		$12K Buy
+605
New +$11.2K ﹤0.01% 438

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Ropes Wealth Advisors's MRNA Position: Q3 2023 in Review

Ropes Wealth Advisors increased its Moderna (MRNA) stake by 18% in Q3 2023, buying an estimated $59.3K and bringing the position to 3,566 shares worth $368K. The position accounts for 0.07% of the portfolio, ranked #191.

Ropes Wealth Advisors first reported a position in MRNA in Q1 2019 and has held it in 19 quarters since. The position peaked at $161M in Q4 2020. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Ropes Wealth Advisors held 3,566 shares of Moderna worth $368K as of Q3 2023.
  • Ropes Wealth Advisors bought 532 Moderna shares in Q3 2023, an estimated $59.3K.
  • Moderna made up 0.07% of Ropes Wealth Advisors's portfolio in Q3 2023, its #191 holding.
  • Ropes Wealth Advisors first reported a position in Moderna in Q1 2019 and has held it in 19 quarters since.
  • Ropes Wealth Advisors's Moderna position peaked at $161M in Q4 2020.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Ropes Wealth Advisors's 13F filing for Q3 2023, filed 19 Oct 2023.